Aligos Therapeutics, Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-212001
- Form type
- 10-Q
- CIK
- 0001799448
- Primary document
- https://www.sec.gov/Archives/edgar/data/1799448/000119312526212001/algs-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aligos Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.8M | - | - |
| Operating Income | $-26.9M | - | - |
| Net Income | $-23.0M | - | - |
| Eps Basic | -2.21 | - | - |
| Eps Diluted | -2.21 | - | - |
| Cash And Equivalents | $30.0M | - | - |
| Total Assets | $64.6M | - | - |
| Total Liabilities | $32.8M | - | - |
| Shareholders Equity | $31.8M | - | - |
| Operating Cash Flow | $-23.1M | - | - |